MARKET

NUS

NUS

Nu Skin Enter
NYSE

Real-time Quotes | Nasdaq Last Sale

57.38
+0.29
+0.51%
After Hours: 57.38 0 0.00% 16:42 06/18 EDT
OPEN
56.92
PREV CLOSE
57.09
HIGH
57.91
LOW
56.44
VOLUME
694.92K
TURNOVER
--
52 WEEK HIGH
63.85
52 WEEK LOW
36.38
MARKET CAP
5.74B
P/E (TTM)
13.67
1D
5D
1M
3M
1Y
5Y
Nu Skin Enterprises To Present At Jefferies Consumer Conference
/PRNewswire/ -- Nu Skin Enterprises, Inc. (NYSE: NUS) today announced announced President and CEO-elect Ryan Napierski and Chief Financial Officer Mark Lawrence will present at the Jefferies Virtual Consumer Conference on Tuesday, June 22, 2021. They will ...
PR Newswire - PRF · 1d ago
4 Cosmetic Stocks to Watch as Consumers Get Ready to Head Out
Zacks.com · 2d ago
Inter Parfums (IPAR) Looks Solid, Gains More Than 35% in 6 Months
Zacks.com · 06/10 15:19
Nu Skin Shines After 3 Quarters Double- And Triple-Digit Profit, Sales Growth
A Relative Strength Rating upgrade for Nu Skin Enterprises Inc shows improving technical performance. Will it continue?
Investor's Business Daily · 06/09 23:23
Helen of Troy (HELE) Spins Off Market Personal Care Business
Zacks.com · 06/09 12:41
Zacks Industry Outlook Highlights: Estee Lauder, Coty, Nu Skin and Inter Parfums
Zacks.com · 06/08 12:14
4 Cosmetics Stocks Stealing Attention Despite Industry Woes
Zacks.com · 06/07 13:06
Nu Skin Enterprises, Inc.'s (NYSE:NUS) Stock Has Seen Strong Momentum: Does That Call For Deeper Study Of Its Financial Prospects?
Nu Skin Enterprises' (NYSE:NUS) stock is up by a considerable 18% over the past three months. As most would know...
Simply Wall St. · 06/07 11:03
More
Forecast
Actual (USD)
Estimate (USD)
Income StatementMore
Net Income (USD)
YoY (%)
Balance SheetMore
Total Assets (USD)
Total Liabilities (USD)
Debt to Asset (%)
Cash FlowMore
Operating (USD)
YoY (%)
Learn about the latest financial forecast of NUS. Analyze the recent business situations of Nu Skin Enter through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 6 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target
The average NUS stock price target is 66.00 with a high estimate of 80.00 and a low estimate of 60.00.
EPS
Institutional Holdings
Institutions: 418
Institutional Holdings: 47.03M
% Owned: 46.99%
Shares Outstanding: 100.08M
TypeInstitutionsShares
Increased
92
3.63M
New
53
1.37M
Decreased
86
2.28M
Sold Out
42
1.09M
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Personal Products
-1.56%
Personal & Household Products & Services
-1.53%
Key Executives
Chairman/Executive Director
Steven Lund
President/Director
Ryan Napierski
Chief Executive Officer/Director
Ritch Wood
Chief Financial Officer/Executive Vice President
Mark Lawrence
Executive Vice President/Chief Scientific Officer
Joseph Chang
Executive Vice President/General Counsel
D. Dorny
Chief Accounting Officer
James Thomas
Executive Vice President
Connie Tang
Lead Director/Independent Director
Daniel Campbell
Director
Emma Battle
Independent Director
Andrew Lipman
Independent Director
Laura Nathanson
Independent Director
Thomas Pisano
Independent Director
Zheqing Shen
Independent Director
Edwina Woodbury
Declaration Date
Dividend Per Share
Ex-Div Date
05/05/2021
Dividend USD 0.38
05/27/2021
02/10/2021
Dividend USD 0.38
02/25/2021
11/04/2020
Dividend USD 0.375
11/25/2020
08/05/2020
Dividend USD 0.375
08/27/2020
05/06/2020
Dividend USD 0.375
05/28/2020
02/12/2020
Dividend USD 0.375
02/27/2020
11/05/2019
Dividend USD 0.37
11/27/2019
08/06/2019
Dividend USD 0.37
08/29/2019
04/30/2019
Dividend USD 0.37
05/30/2019
02/13/2019
Dividend USD 0.37
02/22/2019
11/07/2018
Dividend USD 0.365
11/29/2018
08/02/2018
Dividend USD 0.365
08/30/2018
04/26/2018
Dividend USD 0.365
05/24/2018
02/05/2018
Dividend USD 0.365
02/23/2018
10/30/2017
Dividend USD 0.36
11/16/2017
08/03/2017
Dividend USD 0.36
08/23/2017
05/04/2017
Dividend USD 0.36
05/24/2017
02/17/2017
Dividend USD 0.36
02/23/2017
11/04/2016
Dividend USD 0.355
11/16/2016
08/08/2016
Dividend USD 0.355
08/24/2016
About NUS
Nu Skin Enterprises, Inc. is a holding company. The Company through Nu Skin, a global direct selling company is engaged in developing and distributing personal care products and wellness products that are sold worldwide under the Nu Skin, Pharmanex and ageLOC brands. Nu Skin offers beauty and personal care products, which includes 180 System, AP 24, Body, DR. Dana, Epoch, Nu Colour, Nutricentials, Tri-Phasic White, Tru Face and Sunright. Pharmanex offers nutritional products, including ageLOC R2, ageLOC Vitality, ageLOC Youth, g3, LifePak, TR90 and S3 Scanner. Its ageLOC provides anti-aging products, which includes Facial Spa, Me, LumiSpa, TFEU and Transformation products. The Company operates through nine segments, which consists of seven geographic Nu Skin segments, including Mainland China, South Korea, Southeast Asia, Americas/Pacific, Hong Kong/Taiwan, Europe, Middle East and Africa (EMEA), and Japan. Its segments also include Manufacturing segment and Grow Tech segment.

Webull offers kinds of Nu Skin Enterprises, Inc. stock information, including NYSE:NUS real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, NUS stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading NUS stock methods without spending real money on the virtual paper trading platform.